Beta cell under chronic hyperglycemia
A pancreatic beta cell synthesizes proinsulin continuously. Proinsulin folding requires three disulfide bonds and passage through the ER, so the folding load scales with secretory demand. Under sustained high glucose, the load rises. Early UPR output is adaptive: PERK slows translation and induces ATF4-dependent antioxidant and amino acid programs, ATF6 expands BiP and PDI, and IRE1-XBP1s expands ER membrane and ERAD. If the demand is sustained, CHOP accumulates, BCL-2 is repressed, BIM and PUMA rise, and GADD34 restores translation into an unresolved deficit. The cell's apoptotic threshold falls while the folding deficit persists.
The outcome is set by whether the deficit resolves
The identity of the stressor does not determine the outcome. The outcome is determined by whether the folding deficit resolves within the window in which the adaptive outputs can still restore homeostasis. If it does, the response shuts off and the cell returns to baseline. If it does not, the same three transducers produce pro-apoptotic outputs and the cell dies.
Secretory cell types that run the UPR at high baseline
- Pancreatic beta cells, which fold proinsulin with three disulfide bonds
- Plasma cells, which secrete large quantities of immunoglobulin
- Hepatocytes, which synthesize and secrete albumin, apolipoproteins, and clotting factors
- Osteoblasts, which deposit large amounts of collagen during matrix formation
- Exocrine pancreatic acinar cells, which secrete digestive enzymes
A common confusion
It is tempting to read the UPR as a protective program that can fail and become a death program. It is more accurate to read it as one program whose outputs change with duration. The pro-apoptotic arm is not a separate pathway recruited when protection fails; it is the same three transducers running past the point at which their outputs can restore folding homeostasis.